FGF2 and neoplasm: From the clinical side, the prognostic value of bFGF was evaluated in the serum of 74 RCC patients; through this evaluation, it was discovered that metastasized patients revealed higher bFGF expression and lower long-term survival [147]; also highlighted was the correlation of its high expression with tumor growth and unfavorable prognosis [40].